INMEDBIO

inmedbio-logo

InMEDBio develops safe, cost-effective and comprehensive wound care dressing.

#SimilarOrganizations #Website #More

INMEDBIO

Social Links:

Industry:
Health Care Medical

Address:
Charlottesville, Virginia, United States

Country:
United States

Website Url:
http://www.inmed.bio

Total Employee:
1+

Status:
Active

Contact:
(920) 279-4425

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Euro GStatic Google Static Content Google Cloud QUIC


Similar Organizations

candela-medical-logo

Candela Medical

Candela Medical is aesthetic device company with a comprehensive product portfolio.

theranostec-logo

Theranostec

Theranostec is a developer of effective and safe anti-cancer therapies.

vixiar-medical-logo

Vixiar Medical

Vixiar Medical develops non-invasive, cost-effective devices and systems for monitoring cardiopulmonary diseases.

Official Site Inspections

http://www.inmed.bio

  • Host name: unalocated.63.wixsite.com
  • IP address: 185.230.63.186
  • Location: Ashburn United States
  • Latitude: 39.018
  • Longitude: -77.539
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20147

Loading ...

More informations about "InMEDBio"

Home | inmedbio

We are developing a safe, cost-effective and comprehensive wound care dressing to help prevent infections, and accelerate the healing of chronic wounds.See details»

About - InMed Pharmaceuticals

In parallel to InMed’s therapeutic development programs in skin and ocular diseases, InMed is developing a cannabinoid synthesis manufacturing system called IntegraSyn TM to produce cost-effective, pharmaceutical-grade, bio …See details»

InMed Pharmaceuticals - LinkedIn

InMed’s pipeline consists of three drug development programs in the treatment of Alzheimer’s, ocular and dermatological indications. Together with our subsidiary BayMedica, we are a …See details»

Inmedbio Llc - Drug pipelines, Patents, Clinical trials - Synapse

Explore Inmedbio Llc with its drug pipeline, therapeutic area, technology platform, .See details»

InMed Pharmaceuticals - LinkedIn

InMed Pharmaceuticals is a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates targeting the CB1/CB2 receptors.See details»

InMed Pharmaceuticals Provides Business Update and Milestones …

Jan 16, 2024 InMed Pharmaceuticals is a global leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs. Together with …See details»

InMEDBio - Crunchbase Company Profile & Funding

InMEDBio develops safe, cost-effective and comprehensive wound care dressing.See details»

InMed Pharmaceuticals Increases Cannabinoid Yield to 5 g/L with ...

Jun 17, 2021 InMed’s cannabinoid yield of 5 g/L significantly exceeds currently reported industry yields. The Company has continued to make important steps to further optimize the …See details»

InMed Pharmaceuticals Inc. (NASDAQ: INM) Is ‘One to Watch’

Aug 3, 2021 InMed has a world class leadership team with a successful track record of drug development and commercialization; ... is a bio-med news and content distribution company …See details»

InMed Pharmaceuticals to Present at the 2021 BIO Digital …

Jun 9, 2021 VANCOUVER, British Columbia, June 09, 2021 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a clinical-stage company …See details»

InMed Pharmaceuticals Announces Commencement of Phase 2

Sep 30, 2021 About InMed: InMed Pharmaceuticals is a clinical-stage company developing a pipeline of cannabinoid-based pharmaceutical drug candidates, initially focused on the …See details»

InMed Pharmaceuticals Inc. - Life Sciences British Columbia

Sep 30, 2021 InMed Pharmaceuticals Files Additional Patent Application for INM-901 in the Treatment of Neurodegenerative Conditions Including Alzheimer’s Disease. October 22, 2024. …See details»

InMed Pharmaceuticals to Present at the 2021 BIO Digital …

Jun 9, 2021 VANCOUVER, British Columbia, June 09, 2021 (GLOBE NEWSWIRE) — InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a clinical-stage company …See details»

InMed Pharmaceuticals Achieves 2g/L Cannabinoid Yield with

Apr 26, 2021 About InMed: InMed Pharmaceuticals is a clinical-stage company developing a pipeline of cannabinoid-based pharmaceutical drug candidates, initially focused on the …See details»

InMed Pharmaceuticals to Present at the BIO Investor Forum

Oct 18, 2019 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a biopharmaceutical company developing a proprietary biosynthesis... InMed …See details»

InMed Pharmaceuticals Signs Definitive Agreement to Acquire

Sep 13, 2021 InMed’s proprietary cannabinoid manufacturing process, IntegraSyn™, combined with BayMedica’s synthetic biology and chemical synthesis capabilities, will provide InMed with …See details»

Presentation of Inmed

Inmed is one of the most important neuroscience research center in France. It is a mixed structure Inserm – Aix-Marseille University, directed by Rosa Cossart. The main research topics are …See details»

InMed Pharmaceuticals Inc. (INM) Stock Price, News, Quote

InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States. It operates through two segments: InMed …See details»

Mediterranean Neurobiology Institute | NeuroMarseille

The Institute of Mediterranean Neurobiology (INMED) is a leading Neuroscience Centre affiliated to INSERM and Aix-Marseille University. INMED investigates the development and plasticity of …See details»

linkstock.net © 2022. All rights reserved